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Alexandria Vigil BSN, RN, CEN
Introduction
• My future father-in-law was 
diagnosed with celiac disease 
(CD) approximately 2 years ago.
• He was 60 years old at the time of 
diagnosis and suffered with 
diarrhea and abdominal pain for a 
year prior to being told he had CD.
• My fiancé and daughter are at 
increased risk of developing CD 
due to the genetic/hereditary 
component of the disease. 
• Those who have a first-degree 
relative with CD have a 4% to 17% 
increased risk of developing the 
disease compared to the general 
population (Cui, Basen, Philipp, 
Yusin, & Krishnaswamy, 2017). 
About CD
• CD was fist described by Samuel 
Gee in 1887 and it wasn’t until 
1941 that wheat was hypothesized 
as the possible offending agent, 
noted by William Dicke (Leonard, 
Sapone, Catassi, & Fasano, 2017 
). 
• CD was once thought to almost 
exclusively affect young 
Caucasian children, but can 
actually occur at any age and can 
affect almost any race (Leonard et 
al., 2017).
• The prevalence of  CD is 
estimated to be 0.6% to 1% 
worldwide with approximately 
0.7% to 0.8% of the United States 
(US) population being affected 
(Cui et al., 2017).
• Non-Hispanic whites have an 
approximately  4-8 times greater 
prevalence of CD compared to 
other races (Mardini, Westgate, & 
Grigorian, 2015 ). 
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• The inflammatory process 
described results in small 
histologic abnormalities including: 
• “atrophy of the 
intestinal villi, 
hypertrophy of the 
crypts and 
lymphocytic 
infiltration of 
intraepithelial spaces 
and lamina 
propria”(Adelman, et 
al., 2018).
• Intestinal villi, pictured below, are 
finger-like projections that line the 
intestinal walls, allowing 
absorption and digestion of 
nutrients. (Celiac Disease 
Foundation [CDF], 2017).
• Undiagnosed CD, results in the 
continued ingestion of gluten, 
which  results in continuous 
inflammation that erodes and 
flattens the villi, causing inefficient 
uptake of nutrients as they pass 
through the intestines (CDF, 
2017).
Significance of Pathophysiology
• Diagnosis of CD includes serologic 
and genetic testing, as well as 
duodenal biopsy if positive results 
are found in the initial tests (Cui et 
al., 2017).
• Duodenal biopsy is performed via 
upper endoscopy where 2 samples 
are obtained from the duodenal bulb 
and at least 4 from the rest of the 
duodenum (Cui et al., 2017).
• Samples are then examined, mainly 
assessing the extent of villous 
atrophy.
• The extent of atrophy is classified 
based on the Marsh scale, a seven 
level classification system, with a 0 
indicating normal intestinal villi, and 
a 4 indicating flat, fully atrophied 
intestinal villi (CDF, 2017).
• The picture below depicts the Marsh 
Scale Classification in the 
assessment of villous atrophy.
• The gold standard for diagnosis of 
CD is villous atrophy on biopsy and 
return of normal villi after adherence 
to a gluten free diet (Cui et al., 
2017).
• This test has a high sensitivity and 
specificity and is the first test that 
should be ordered when CD is 
suspected (Leonard et al., 2017).
• If serum IgA levels are < 0.2%, or 
the patient is younger than 2 years 
of age, then the test of choice is 
measurement of  IgG levels to 
DGP (Cui et al., 2017). 
• Genetic testing can be considered 
for patient’s whose serologic and 
histologic results are inconsistent 
(Cui et al., 2017).
• In addition to duodenal biopsy, 
serologic and genetic testing can be 
performed for diagnosis of CD.
• Serologic testing measures the levels 
of:
• anti-tissue 
transglutaminase (tTG)
• Anti-endomysium 
(EMA) 
• Anti-deamidated gliadin 
peptides (DGP) (Green 
et al., 2015).
• First line testing to screen for CD 
includes measurement of serum IgA 
antibodies to tTG (Leonard et al., 
2017).
Diagnostic Testing 
Signs and Symptoms 
(The University of Chicago Celiac 
Disease Center, n.d.)
• The classic presentation of CD manifests as gastrointestinal (GI) symptoms of diarrhea, 
abdominal pain/distension and malnutrition, resulting in poor growth/failure to thrive in children 
(Robinson, Davis, Vess, & Lebel, 2015).
• However, the clinical presentation of CD varies from patient to patient with ailments presenting 
as both intestinal and extra-intestinal symptoms (Green, Lebwohl, & Greywoode, 2015).
• Intestinal symptoms include:
• diarrhea, bloating, constipation, abdominal pain or weight loss (Leonard et al., 
2017).
• Extra-intestinal symptoms include:
• iron-deficiency anemia, dermatitis herpetifromis, vitamin deficiencies, 
neurological or psychiatric problems and infertility (Lebwohl, Ludvigsson & Green, 
2015). 
Underlying Pathophysiology
• CD is an autoimmune disorder occurring in genetically predisposed individuals.
• Individuals who are genetically predisposed to CD  have the  HLA-DQ2 or HLA-DQ8 
haplotype (Lebwohl et al., 2015).
• While 30-40% of the general population are carriers for at least one of these alleles, the 
absence of either allele has a “negative predictive value of 100% in excluding the diagnosis of 
CD” (Green et al., 2015). 
• The pathogenesis of CD is dependent not only on being genetically predisposed to the 
disease , but is also dependent on exposure to gluten and other environmental factors (Green 
et al., 2015).
• Gluten is the storage protein present in wheat, rye and barely (Cui et al., 2017).
• It is a mixture of gliadin and glutenin’s, complex proteins that are not completely digested by 
intestinal enzymes. This triggers an inflammatory process, as these proteins are mistaken as  
pathogens (Leonard et al., 2017).
• Partially digested gliadins then enter through the epithelial barrier of the small intestinal 
mucosa,  triggering innate and adaptive immune responses (Lebwohl et al., 2015).
• Once through the epithelial barrier, gliadins are “deamidated by the enzyme transglutaminase 
(TTG)” (Green et al., 2015). 
• This process increases the immunogenicity of gliadin, by altering the charge that facilitates 
binding to the HLA-DQ2 or HLA-DQ8 molecule on antigen presenting cells (Lebwohl et al., 
2015).
• Gliadin CD4 positive T cells recognize gliadin peptides and in turn produce proinflammatory 
cytokines (Lebwohl et al., 2015).
• During the inflammatory cascade, the release of metalloproteinases and other tissue 
damaging mediators cause tissue injury, leading to epithelial lesions which cause the 
symptoms seen in the clinical manifestations of CD (Lebwohl et al., 2015).
• Other environmental factors have been attributed to the pathogenesis of CD, including 
infections of the GI tract and alterations in the intestinal microbiota (Green et al., 2015). 
• Examples of intestinal alterations include bacteria such as the Bacteroides species, which are 
thought to play a pathogenic role in the development and manifestation of symptoms in CD 
(Green et al., 2015).
(Lebwohl et al., 2015)
(Adelman et al., 2018)
Implications for Nursing 
• CD is increasing in prevalence, although it is 
generally underdiagnosed (Green et al., 2015 ).
• Therefore, it is important for healthcare providers to 
recognize not only the GI symptoms present in CD 
but to also assess the cause of any extra-intestinal 
findings as well.
• Patient’s with otherwise unexplained 
iron-deficiency anemia, as well as 
those who do not respond to oral iron 
therapy, should be tested for celiac 
disease (Leonard et al., 2017).
• CD commonly leads to nutritional deficiencies such 
as: 
• iron, folic acid, vitamin B12 and B6, 
copper, zinc and vitamin D deficiencies 
(Cui et al., 2017).
• Delayed diagnosis of CD showed more severe 
villous atrophy at diagnosis, which predicted slower 
mucosal healing in the one year follow-up biopsy, as 
detailed in a study performed by Pekki et al. (2015).
• Increasing provider awareness about celiac disease 
could improve healthcare-associated costs by 
preventing repetitive testing and misdiagnosis 
(Robinson et al., 2015). 
• Patient education is key in the success of treatment 
for CD, as strict adherence to a gluten free (GF) diet 
is the main therapeutic intervention for this disease 
process (Green et al., 2015).
• Resources should be given to patient’s on how to 
contact a dietician upon diagnosis, as low adherence 
to a GF diet, predisposes patient’s to incomplete 
mucosal recovery, which leads to decreased quality 
of life due to incomplete resolution of intestinal and 
extra-intestinal symptoms (Pekki et al., 2015).
Conclusion
• The reason for an increasing prevalence of CD is 
still unknown, as is the extent to which 
environmental factors other than gluten contribute 
to the development of CD (Green et al., 2015)
• The development of CD occurs among subjects 
with HLA-DQ2 or HLA-DQ8 genes who are 
exposed to gluten and other environmental factors 
(Green et al., 2015).
• Diagnosis of CD is based on characteristic 
autoantibodies seen in serologic testing, as well as 
with small intestinal histological changes upon 
examination of biopsy sample (Green et al., 2015).
• Early diagnosis can prevent the extent of villous 
atrophy seen, which positively correlates to the 
rate of mucosal healing and resolution of 
symptoms seen in CD (Pekki et al., 2015).
• Adherence to a strict GF diet is the best predictor 
of remission of the disease.
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